![Oncoustics](https://parsers.vc/logo/9374e7fd-1094-4208-b481-9122b958aab3-0.webp)
Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, we are not doing image recognition. Instead, we apply AI to raw ultrasound signals from readily available handheld ultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and our approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. (And as our data - >2M pieces of data and growing is part of our IP - we're hard to copy.) Initially, we are targeting liver disease, a $30B global diagnostic market. We have achieved over 93% AUROC for the OnX that detects liver fibrosis - and our 510K is in progress. Several follow-on liver products are in development. We also have clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers. We've been in discussion with several pharma companies and are moving forward on a pilot with Roche and have other traction in that space too.
Location: Canada, Ontario, Toronto
Employees: 11-50
Total raised: $6M
Founded date: 2017
Investors 6
Date | Name | Website |
21.03.2022 | Plug and P... | plugandpla... |
- | Pool Globa... | poolglobal... |
21.03.2024 | Sony Innov... | sonyinnova... |
01.06.2021 | Creative D... | creativede... |
- | Density Ve... | densityven... |
- | NEXT Canad... | directory.... |
Funding Rounds 1
Date | Series | Amount | Investors |
25.07.2022 | Seed | $6M | - |
Mentions in press and media 6
Date | Title | Description |
18.06.2024 | Oncoustics Awarded INOVAIT Focus Fund to Accelerate AI-Driven Liver Diagnostics at Point of Care | Oncoustics Oncoustics AI-driven tissue characterization solutions to improve patient outcomes and reduce the overall cost of healthcare We are thrilled to be part of the INOVAIT network as we develop our novel AI solutions to advance diagno... |
22.07.2022 | This CFO-turned-entrepreneur thinks corporate ‘perks’ are broken—and has a better idea | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. This is reporter Lucy Brewster, filling in for Jessica while she is away. Today, we're diving int... |
22.07.2022 | Oncoustics Closes $5M+ Seed Funding | Oncoustics, a Toronto, Canada-based provider of ultrasound-based tissue characterization solutions, raised $5M+ in Seed funding. The round was led by Creative Ventures and Saltagen Ventures with participation from NorthSpring Capital Partne... |
22.07.2022 | Oncoustics Raises $5M for AI-Driven Point-of-Care Diagnostics | What You Should Know: – Oncoustics, San Francisco, CA-based ultrasound-based tissue characterization solutions announces the initial close of a $5 million+ seed round of funding to advance its SaMD (software as a medical device) technology ... |
21.07.2022 | Oncoustics secures $5.5 million CAD to help spot liver disease using AI | - |
21.07.2022 | Oncoustics raises $6M to detect liver disease using ultrasound signals | The company is looking to expand to the prostate, kidney, breast and thyroid Over 2 billion people globally are living with, or at risk for, liver disease, and many of them don’t even know it. This is being accelerated by the rise of Non Al... |